Cargando…
Novel vectors and approaches for gene therapy in liver diseases
Gene therapy is becoming an increasingly valuable tool to treat many genetic diseases with no or limited treatment options. This is the case for hundreds of monogenic metabolic disorders of hepatic origin, for which liver transplantation remains the only cure. Furthermore, the liver contains 10–15%...
Autores principales: | Maestro, Sheila, Weber, Nicholas D., Zabaleta, Nerea, Aldabe, Rafael, Gonzalez-Aseguinolaza, Gloria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203845/ https://www.ncbi.nlm.nih.gov/pubmed/34159305 http://dx.doi.org/10.1016/j.jhepr.2021.100300 |
Ejemplares similares
-
mRNA and gene editing: Late breaking therapies in liver diseases
por: Zabaleta, Nerea, et al.
Publicado: (2022) -
TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
por: Usai, Carla, et al.
Publicado: (2020) -
AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis (†)
por: Maestro, Sheila, et al.
Publicado: (2021) -
Animal Models of Chronic Hepatitis Delta Virus Infection Host–Virus Immunologic Interactions
por: Aldabe, Rafael, et al.
Publicado: (2015) -
Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice
por: Bazo, Andrea, et al.
Publicado: (2022)